Overview
Employees
11-50 employees
Category
personalized skin
Our Solution – Personalized, bio-engineered, dermo-epidermal skin grafts After more than 15 years of research (Tissue Biology Research Unit, University Children’s Hospital Zurich), CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDA Orphan drug designation for the treatment of burns. Since 2016, CUTISS is supported by WYSS ZURICH, that finances the clinical trial programs and offers the manufacturing facility for DenovoSkin. CUTISS AG operates as a biotechnology company. The Company provides patients that suffer from large and deep skin defects with personalized skin tissue therapy for children and adults. CUTISS serves customers in Switzerland. CUTISS is a Personalized skin startup . CUTISS AG is located in Schlieren, ZÜRICH, Switzerland and is part of the Medical Equipment & Supplies Manufacturing Industry. CUTISS AG has 29 employees at this location and generates $3.68 million in sales (USD). CUTISS AG is located in Schlieren, ZÜRICH, Switzerland and is part of the Medical Equipment & Supplies Manufacturing Industry. CUTISS AG has 29 employees at this location and generates $3.68 million in sales (USD). (Sales figure is modelled).
